MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, TRDA made $875K in revenue. -$40,123K in net income. Net profit margin of -4585.49%.

Income Overview

Revenue
$875K
Net Income
-$40,123K
Net Profit Margin
-4585.49%
EPS
-$0.95
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Collaboration revenue
875 -7,837* 1,614 -
Research and development
33,054 24,080* 38,361 -
General and administrative
10,124 10,183* 10,304 -
Total operating expenses
43,178 34,263* 48,665 -
Loss from operations
-42,303 -42,100* -47,051 -
Interest and other income
2,624 3,054 3,571 -
Total other income
2,624 3,054* 3,571 -
Loss before provision for income taxes
-39,679 -39,046 -43,480 -42,925
Provision for income taxes
38 118 654 178
Net loss
-39,717 -39,164 -44,134 -43,103
Unrealized (loss) gain on marketable securities
-406 31 221 -37
Total other comprehensive (loss) gain
-406 31 221 -37
Total comprehensive loss
-40,123 -39,133 -43,913 -43,140
Basic EPS
-0.95 -0.94 -1.06 -1.04
Diluted EPS
-0.95 -0.94 -1.06 -1.04
Basic Average Shares
41,836,275 41,610,893 41,462,567 41,338,752
Diluted Average Shares
41,836,275 41,610,893 41,462,567 41,338,752
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Total comprehensiveloss-$40,123K (-137.85%↓ Y/Y)Net loss-$39,717K (-128.93%↓ Y/Y)Total othercomprehensive (loss) gain-$406K (-184.58%↓ Y/Y)Interest and other income$2,624K (-40.91%↓ Y/Y)Loss beforeprovision for income taxes-$39,679K (-128.71%↓ Y/Y)Provision for income taxes$38K Unrealized (loss) gain onmarketable securities-$406K (-184.58%↓ Y/Y)Total other income$2,624K (-40.91%↓ Y/Y)Loss from operations-$42,303K (-94.14%↓ Y/Y)Collaboration revenue$875K (-95.74%↓ Y/Y)Total operatingexpenses$43,178K (1.96%↑ Y/Y)Research and development$33,054K (3.06%↑ Y/Y)General andadministrative$10,124K (-1.46%↓ Y/Y)

Entrada Therapeutics, Inc. (TRDA)

Entrada Therapeutics, Inc. (TRDA)